FACULTY AFFILIATIONS AND DISCLOSURES:

As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Adam P Dicker, MD, PhD Associate Professor and Director, Division of Experimental Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania Financial Disclosure Grants/Research Support: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Novartis Pharmaceuticals

Anna C Ferrari, MD Associate Professor, Director of Genitourinary Cancer Program, Division of Hematology/Oncology, Derald H Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New YorkFinancial Disclosure No financial interests or affliations to disclose

Leonard G Gomella, MD The Bernard W Godwin Professor of Prostate Cancer, Chairman, Department of Urology, Jefferson Medical College, Philadelphia, Pennsylvania Financial Disclosure Consultant: AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, TAP Pharmaceuticals Inc

Eric A Klein, MD Head, Section of Urologic Oncology, Glickman Urological Institute, Professor of Surgery, Cleveland Clinic, Lerner College of Medicine, Cleveland, Ohio Financial Disclosure Consultant: Merck and Company Inc

Laurence Klotz, MD Professor of Surgery, University of Toronto, Chief, Division of Urology Sunnybrook & Women’s College Health Sciences Centre, Toronto, Ontario Financial Disclosure Consultant: Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Novartis Pharmaceuticals

Edward M Messing, MD WW Scott Professor, Chairman, Department of Urology, Professor of Pathology and Oncology, Deputy Director, James P Wilmot Cancer Center, Rochester, New York Financial Disclosure Grants/Research Support and Consultant: AstraZeneca Pharmaceuticals LP

Judd W Moul, MD, FACS Professor and Chief, Division of Urologic Surgery, Duke University Medical Center, Durham, North Carolina Financial Disclosure Honorarium: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Merck and Company Inc, TAP Pharmaceuticals Inc

Mack Roach III MD, FACR Professor, Radiation Oncology and Urology, Vice Chair, Radiation Oncology, Director of Clinical Research, Department of Radiation Oncology, UCSF Comprehensive Cancer Center, San Francisco, California Financial Disclosure Grants/Research Support: Amgen Inc. Consultant and Honorarium: Amgen Inc, AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Cytogen Corporation, TAP Pharmaceuticals Inc. Speakers Bureau: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, TAP Pharmaceuticals Inc

William A See, MD Professor and Chairman, Department of Urology, Medical College of Wisconsin, Milwaukee, Wisconsin Financial Disclosure Grants/Research Support: Abbott Laboratories, AstraZeneca Pharmaceuticals LP Consultant: AstraZeneca Pharmaceuticals LP, Pfizer Inc

Susan F Slovin, MD, PhD Assistant Member, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York Financial Disclosure Consultant: Synarc. Speakers Bureau: AstraZeneca Pharmaceuticals LP, Aventis Pharmaceuticals Inc, Bristol-Myers Squibb Company, Novartis Pharmaceuticals

Mary-Ellen Taplin, MD Assistant Professor of Medicine, The Lank Center of Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Financial Disclosure Grants/Research Support: Aventis Pharmaceuticals Inc. Consultant: Abbott Laboratories. Honorarium: AstraZeneca Pharmaceuticals LP

Ian M Thompson, MD Professor and Chief, Henry B and Edna Smith Dielmann Memorial Fund Chair in Urologic Science, Division of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas Financial Disclosure Grants/Research Support: Abbott Laboratories. Speakers Bureau: AstraZeneca Pharmaceuticals LP. Advisory Board: Mission Pharmaceuticals Ltd

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.